Clinical Trial Results:
A Phase 1/2a, Ascending Multiple-Dose Study to Evaluate the Safety, Efficacy and
Pharmacokinetics of BMS-753493 in Subjects with Advanced Cancer.
Revised Protocol 02, incorporating Protocol Amendment 02 (Version 1.0, Date 17-Oct-2007) and 03 (Version 1.0, Date 26-Nov-2007). And Pharmacogenetics Blood Sample Amendment 01 (Version 3.0, Date 14-Aug-2007).
Summary
|
|
EudraCT number |
2007-001432-31 |
Trial protocol |
NL |
Global completion date |
23 Mar 2010
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
07 Dec 2016
|
First version publication date |
07 Dec 2016
|
Other versions |
|
Summary report(s) |
CA190-001_Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.